Cells (Nov 2022)

The Role of IL-6 in Cancer Cell Invasiveness and Metastasis—Overview and Therapeutic Opportunities

  • Magdalena Rašková,
  • Lukáš Lacina,
  • Zdeněk Kejík,
  • Anna Venhauerová,
  • Markéta Skaličková,
  • Michal Kolář,
  • Milan Jakubek,
  • Daniel Rosel,
  • Karel Smetana,
  • Jan Brábek

DOI
https://doi.org/10.3390/cells11223698
Journal volume & issue
Vol. 11, no. 22
p. 3698

Abstract

Read online

Interleukin 6 (IL-6) belongs to a broad class of cytokines involved in the regulation of various homeostatic and pathological processes. These activities range from regulating embryonic development, wound healing and ageing, inflammation, and immunity, including COVID-19. In this review, we summarise the role of IL-6 signalling pathways in cancer biology, with particular emphasis on cancer cell invasiveness and metastasis formation. Targeting principal components of IL-6 signalling (e.g., IL-6Rs, gp130, STAT3, NF-κB) is an intensively studied approach in preclinical cancer research. It is of significant translational potential; numerous studies strongly imply the remarkable potential of IL-6 signalling inhibitors, especially in metastasis suppression.

Keywords